Two Cases of Wernicke’s Encephalopathy in Young Age Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Wernicke’s encephalopathy is an acute neurolopsychiatric syndrome caused by thiamine deficiency, and classically presents with the triad of opthalmopathy, ataxia and altered mentality. Both prolonged total parenteral nutrition and reduced oral intake can induce Wernicke’s encephalopathy during hematopoietic stem cell transplantation (HSCT). Although early treatment is important for recovery from Wernicke’s encephalopathy, the vague symptoms and characteristics hinder early diagnosis. Furthermore, Wernicke’s encephalopathy is not infrequent and can develop at any age during HSCT. Herein, we present two young patients developing Wernicke’s encephalopathy during HSCT.
Abstract
Wernicke’s encephalopathy is an acute neurolopsychiatric syndrome caused by thiamine deficiency, and classically presents with the triad of opthalmopathy, ataxia and altered mentality. Both prolonged total parenteral nutrition and reduced oral intake can induce Wernicke’s encephalopathy during hematopoietic stem cell transplantation (HSCT). Although early treatment is important for recovery from Wernicke’s encephalopathy, the vague symptoms and characteristics hinder early diagnosis. Furthermore, Wernicke’s encephalopathy is not infrequent and can develop at any age during HSCT. Herein, we present two young patients developing Wernicke’s encephalopathy during HSCT.
참고문헌 (12)
- Husby G, "Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amyloidosis", Amyloid, 1, pp.119~137 (1994)
- Uhlar CM, "Serum amyloid A, the major vertebrate acute-phase reactant", Eur J Biochem, 265, pp.501~523 (1999)
- 정상윤, "Serum Amyloid A as a Useful Indicator of Disease Activity in Patients with Ankylosing Spondylitis", Yonsei Medical Journal, 48(2), pp.218~224 (2007), 연세대학교의과대학
- Lange U, "Serum amyloid A--an indicator of inflammation in ankylosing spondylitis", Rheumatol Int, 19, pp.119~122 (2000)
- Cleary AG, "Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997", J Rheumatol, 27, pp.1568~ (2000)
- O’Hara R, "Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue", Arthritis Res, 2, pp.142~144 (2000)
- Shimojima Y, "Serum amyloid A as a potent therapeutic marker in a refractory patient with polymyalgia rheumatica", Intern Med, 44, pp.1009~1012 (2005)
- de Vries MK, "Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis", Arthritis Rheum, 61, pp.1484~1490 (2009)
- Scheinberg MA, "Serum amyloid protein levels in south american children with rheumatoid arthritis: a co-operative study", Ann Rheum Dis, 39, pp.228~230 (1980)
- Hachulla E, "Serum amyloid A concentrations in giant-cell arteritis and polymyalgia rheumatica: a useful test in the management of the disease", Clin Exp Rheumatol, 9, pp.157~163 (1991)
- Hagihara K, "IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system", Biochem Biophys Res Commun, 314, pp.363~369 (2004)
- Yamada T., "Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness", Clin Chem Lab Med, 37, pp.381~388 (1999)